FGF21 and metabolic dysfunction-associated steatotic liver disease: Furthermore, in all MASLD patients complement 2 was repressed (Figure S12A,B), and except of C2, COLEC10 and C4BPB, the correlation between FGF21 and the expression of complement factors was strictly negative.